This report provides an overview of HIV prevention activities conducted and supported by the Division of HIV/AIDS Prevention during the Fiscal Year 2011 (October 2010-September 2011). These achievements are made possible by the extraordinary commitment of our partners on the front lines of the HIV epidemic – health departments, community-based organizations (CBOs), people living with HIV, researchers, health care providers, and many more.
Los Angeles County Commission Meeting on HIV located at the Foundation Conference Room, St. Anne’s Maternity Home on June 12, 2008. The meeting discussed the prevention planning committee report, State Office of AIDS Report Public Health/Health Care Agency Reports, and Office of AIDS Programs and Policy Report. The meeting listed out committee members including those from the Operations Committee, Joint Public Policy (JPP) Committee, Standards of Care (SOC) Committee, and the Priorities & Planning (P&P) Committee
The WHO is developing guidelines for evidence-based interventions for the prevention and treatment of HIV and other STIs in low- and middle-income countries. As a global partner to the WHO in this process, the Global Network of Sex Work Projects oversaw a civil society consultation of sex workers commissioned by the WHO to gather feedback on proposed guidelines. This report contains the findings from that consultation and was submitted to the WHO.
This final study report highlighted the results of three focus groups and five key informant interviews that were conducted to assess potential barriers to the acceptance and use of biomedical HIV prevention strategies. A modified grounded-theory approach was used to analyze the interview and focus-group data.
Results of a small pilot trial of a multicomponent (behavioral strategies, simplified patient information, and social support) and multidisciplinary (cognitive-behavioral therapy and nursing) medication adherence intervention was conducted for HIV-infected adults prescribed antiretrovirals. The intervention, however, did not appear to affect health-related anxiety or to significantly improve adherence to dose. Implications for future intervention planning are discussed.